Medindia

X

Reportlinker Adds Asia Pacific Pharma Sector Analysis

Friday, November 13, 2009 General News J E 4
Advertisement


NEW YORK, Nov. 12 Reportlinker.com announces that a new market research report is available in its catalogue.

Asia Pacific Pharma Sector Analysis

http://www.reportlinker.com/p0163724/Asia-Pacific-Pharma-Sector-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region has seen significant developments in the field of contract manufacturing, particularly in generics and APIs. Several technological advancements have also boosted the R&D activities in the region, helping the market to grow at double digit growth rate in recent years. The size of the Asia-Pacific pharma market is estimated at around US$ 187 Billion for 2009.

According to our latest research report "Asia Pacific Pharma Sector Analysis", the future of pharma industry in the Asia-Pacific region remains bright, and the industry is projected to grow at a CAGR of around 12.6% during 2010-2012. The growth will mainly be driven by low cost factors, changing regulatory environment and increased private sector investments in the industry. Currently, the market is characterized by high growth of generics, and the same trend will continue in near future also.

We have found that the region will become the global API production hub in next few years, backed by low cost manufacturing, favorable regulatory environment and current advancements in the production technology. Also, the market will show significant changes in terms of sales and marketing model, which will be changed into tender-based model, favoring the sales of low cost drugs, and thus resulting in intense competition among key players.

Our research reveals that the pharma sales are growing rapidly in countries like India, China, Malaysia, South Korea and Indonesia. This growth is mainly attributed to the increase in disposable income along with the emergence of several health insurance schemes, which are giving a boost to the sales of branded drugs. Besides this, the intense competition among key players in the region has been easing the availability of low cost drugs, thus providing a further boost to the market growth.

Our report provides an extensive and objective analysis on the Asia-Pacific pharma market. It provides analytical and statistical information on regional level markets, including their market size and segmentation. It also features an analysis on the future directions, supplemented with various facts and figures. Thus, the report serves as a useful guide for pharmaceutical companies, government officials, consultants and investors who are planning to enter the Asia-Pacific pharma market.

1. Analyst View

2. Global Pharmaceutical Market Overview

2.1 Market Size and Growth

2.2 Leading Drugs

3. Asia-Pacific Pharmaceutical Market Overview

4. Pharmaceutical Market By Country

4.1 China

4.1.1 Market Overview

4.1.2 Future Outlook

4.1.3 Regulatory Environment

4.2 India

4.2.1 Market Overview

4.2.2 Future Outlook

4.2.3 Regulatory Environment

4.3 Japan

4.3.1 Market Overview

4.3.2 Future Outlook

4.3.3 Regulatory Environment

4.4 South Korea

4.4.1 Market Overview

4.4.2 Future Outlook

4.4.3 Regulatory Environment

4.5 Indonesia

4.5.1 Market Overview

4.5.2 Future Outlook

4.5.3 Regulatory Environment

4.6 Vietnam

4.6.1 Market Overview

4.6.2 Future Outlook

4.6.3 Regulatory Environment

4.7 Thailand

4.7.1 Market Overview

4.7.2 Future Outlook

4.7.3 Regulatory Environment

4.8 Philippines

4.8.1 Market Overview

4.8.2 Future Outlook

4.8.3 Regulatory Environment

4.9 Malaysia

4.9.1 Market Overview

4.9.2 Future Outlook

4.9.3 Regulatory Environment

4.10 Australia

4.10.1 Market Overview

4.10.2 Future Outlook

4.10.3 Regulatory Environment

4.11 New Zealand

4.11.1 Market Overview

4.11.2 Future Outlook

4.11.3 Regulatory Environment

5. Emerging Market Trends

5.1 Contract Manufacturing

5.2 Vaccine Market

5.3 Generics

5.4 Medical Tourism Market

6. Industry Restraints and Recommendation

6.1 IPR Protection

6.2 Regulatory Issues

6.3 Reimbursement Issues

6.4 Low Investments in R&D

7. Competitive Landscape

7.1 GlaxoSmithKline plc

7.2 Pfizer Inc

7.3 Sanofi-Aventis

7.4 Ranbaxy Laboratories Limited

7.5 Takeda Pharmaceutical Company Limited

List of Figures:

Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2004-2009

Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2004-2008

Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 3-1: Asia-Pacific - Pharmaceutical Market (Billion US$), 2007-2009

Figure 3-2: Asia-Pacific - Pharmaceutical Market by Country (%), 2008

Figure 3-3: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 3-4: Asia-Pacific - Forecast for Pharmaceutical Market by Country (%), 2012

Figure 4-1: China - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-2: China - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)

Figure 4-3: China - Share of Generic Drugs in Pharma Market (2008)

Figure 4-4: China - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 4-5: India - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-6: India - Pharmaceutical Exports (Billion INR), 2007-08 & 2008-09

Figure 4-7: India - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 4-8: Japan - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-9: Japan - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)

Figure 4-10: Japan - Share of Generics and Branded Drugs in Pharma Market (2008)

Figure 4-11: Japan - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 4-12: South Korea - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-13: South Korea - Share of OTC and Prescription Drugs in Pharma Market (2008)

Figure 4-14: South Korea - Share of Generics and Branded Drugs in Pharma Market (2008)

Figure 4-15: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 4-16: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2009

Figure 4-17: Indonesia - Share of OTC and Prescription Drugs in Pharma Market (2008)

Figure 4-18: Indonesia - Share of Generics and Branded Drugs in Pharma Market (2008)

Figure 4-19: Indonesia - Forecast for Pharmaceutical Market (Trillion Rp), 2010-2012

Figure 4-20: Vietnam - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-21: Vietnam - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)

Figure 4-22: Vietnam - Share of Generics and Branded Drugs in Pharma Market (2008)

Figure 4-23: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 4-24: Thailand - Pharmaceutical Market (Billion THB), 2007-2009

Figure 4-25: Thailand - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)

Figure 4-26: Thailand - Share of Branded and Generics Drugs in Pharma Market (2008)

Figure 4-27: Thailand - Forecast for Pharmaceutical Market (Billion THB), 2010-2012

Figure 4-28: Philippines - Pharmaceutical Market (Billion PHP), 2007-2009

Figure 4-29: Philippines - Share of OTC, Prescription & Nutritional Drugs in Pharma Market (2008)

Figure 4-30: Philippines - Market Structure of the Pharmaceutical Industry

Figure 4-31: Philippines - Share of Foreign and Domestic Firms in Pharma Market (2008)

Figure 4-32: Philippines - Forecast for Pharmaceutical Market (Billion PHP), 2010-2012

Figure 4-33: Malaysia - Pharmaceutical Market (Million US$), 2007-2009

Figure 4-34: Malaysia - Share of Generics and Branded Drugs in Pharma Market (2008)

Figure 4-35: Malaysia - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)

Figure 4-36: Malaysia - Forecast for Pharmaceutical Market (Million US$), 2010-2012

Figure 4-37: Australia - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-38: Australia - Share of Generics and Branded Drugs in Pharma Market (2008)

Figure 4-39: Australia - Pharmaceutical Export by Destination (%), 2006

Figure 4-40: Australia - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 4-41: New Zealand - Pharmaceutical Market (Billion US$), 2007-2009

Figure 4-42: New Zealand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012

Figure 5-1: Global - Pharmaceutical Contract Manufacturing Market (Billion US$), 2008-2012

Figure 5-2: Asia-Pacific - Generics Market (Billion US$), 2007-2009

Figure 5-3: Asia - Medical Tourism Market (Billion US$), 2007-2009

Lists of Tables:

Table 2-1: Global - Leading Drugs by Sales (Billion US$), 2008

Table 4-1: China - Healthcare Statistics (2007-2009)

Table 4-2: China - Timeframe for New Drug Review

Table 4-3: India - Healthcare Statistics (2007-2009)

Table 4-4: Japan - Healthcare Statistics (2007-2009)

Table 4-5: South Korea - Healthcare Statistics (2007-2009)

Table 4-6: Indonesia - Healthcare Statistics (2007-2009)

Table 4-7: Vietnam - Healthcare Statistics (2007-2009)

Table 4-8: Thailand - Healthcare Statistics (2007-2009)

Table 4-9: Philippines - Healthcare Statistics (2007-2009)

Table 4-10: Malaysia - Healthcare Statistics (2007-2009)

Table 4-11: Australia - Healthcare Statistics (2007-2009)

Table 4-12: New Zealand - Healthcare Statistics (2007-2009)

Table 7-1: GlaxoSmithKline plc - Strengths & Weaknesses

Table 7-2: Pfizer Inc - Strengths & Weaknesses

Table 7-3: Sanofi-Aventis - Strengths & Weaknesses

Table 7-4: Ranbaxy Laboratories Limited - Strengths & Weaknesses

Table 7-5: Takeda Pharmaceutical - Strengths & Weaknesses

To order this report:

Asia Pacific Pharma Sector Analysis

http://www.reportlinker.com/p0163724/Asia-Pacific-Pharma-Sector-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)-652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
PD-Rx Pharmaceuticals, Inc. Reports Earnings for 2...
S
Reportlinker Adds Deoxyarbutin (CAS 497-76-7) Mark...